C. S. Venugopalan

591 total citations
36 papers, 482 citations indexed

About

C. S. Venugopalan is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, C. S. Venugopalan has authored 36 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in C. S. Venugopalan's work include Asthma and respiratory diseases (14 papers), Neuropeptides and Animal Physiology (8 papers) and Respiratory and Cough-Related Research (7 papers). C. S. Venugopalan is often cited by papers focused on Asthma and respiratory diseases (14 papers), Neuropeptides and Animal Physiology (8 papers) and Respiratory and Cough-Related Research (7 papers). C. S. Venugopalan collaborates with scholars based in United States, India and Japan. C. S. Venugopalan's co-authors include Jeffrey M. Drazen, Kevin M. Kleinow, Warren M. Gold, Sarah E. Chesrown, Christopher H. Fanta, Peter G. Lacouture, Zeen Tong, Margaret O. James, Nicholas A. Soter and Terry Gordon and has published in prestigious journals such as Journal of Clinical Investigation, Environmental Health Perspectives and Journal of Applied Physiology.

In The Last Decade

C. S. Venugopalan

35 papers receiving 447 citations

Peers

Countries citing papers authored by C. S. Venugopalan

Since Specialization

Citations

This map shows the geographic impact of C. S. Venugopalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. S. Venugopalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. S. Venugopalan more than expected).

Fields of papers citing papers by C. S. Venugopalan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. S. Venugopalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. S. Venugopalan. The network helps show where C. S. Venugopalan may publish in the future.

Co-authorship network of co-authors of C. S. Venugopalan

This figure shows the co-authorship network connecting the top 25 collaborators of C. S. Venugopalan. A scholar is included among the top collaborators of C. S. Venugopalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. S. Venugopalan. C. S. Venugopalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vitro response of large colon arterial and venous rings to vasodilating drugs in horses 1999 ·American Journal of Veterinary Research ·(unknown), C. S. Venugopalan, (unknown), Catherine Koch, Rustin M. Moore	2
2	Biphasic responses of equine colonic vessel rings to vasoactive inflammatory mediators 1998 ·Journal of Autonomic Pharmacology ·C. S. Venugopalan, R. M. Moore, (unknown), (unknown), Catherine Koch	15
3	Bioavailability and biotransformation of benzo(a)pyrene in an isolated perfused In situ catfish intestinal preparation. 1998 ·Environmental Health Perspectives ·Kevin M. Kleinow, Margaret O. James, Zeen Tong, C. S. Venugopalan	52
4	Responses of Guinea-Pig Lung Parenchymal Strips to Tracheobronchial Lavage Fluid from Horses affected with Summer Pasture-Associated Obstructive Pulmonary Disease 1998 ·Veterinary Research Communications ·C. S. Venugopalan, Ron Beadle, Thomas L. Seahorn, (unknown)	2
5	Involvement of nitric oxide in the mediation of NANC inhibitory neurotransmission of guinea‐ pig trachea 1998 ·Journal of Autonomic Pharmacology ·C. S. Venugopalan, (unknown), (unknown), T. Maher	4
6	Sedative and analgesic effects of medetomidine in beagle dogs infected and uninfected with heartworm 1998 ·Veterinary Research Communications ·C. S. Venugopalan, (unknown), (unknown), (unknown), (unknown)	2
7	Role of endothelium and nitric oxide in the in vitro response of equine colonic venous rings to vasoconstrictor agents 1997 ·American Journal of Veterinary Research ·Rustin M. Moore, C. S. Venugopalan, (unknown), (unknown)	3
8	Role of Endothelium and Nitric Oxide in the Response of Equine Colonic Arterial Rings to Vasoconstrictor Agents 1997 ·Veterinary Surgery ·C. S. Venugopalan, Rustin M. Moore, (unknown), (unknown)	10
9	Evidence for serotonin involvement in the NAIMC excitatory neurotransmission in the catfish intestine 1995 ·Journal of Autonomic Pharmacology ·C. S. Venugopalan, (unknown), Kevin M. Kleinow	9
10	Large bowel transit times using radiopaque markers in normal cats 1995 ·Journal of the American Animal Hospital Association ·(unknown), Robert D. Pechman, Cheryl S. Hedlund, C. S. Venugopalan	12
11	Cardiopulmonary effects of medetomidine in heartworm-infected and noninfected dogs 1994 ·American Journal of Veterinary Research ·C. S. Venugopalan, (unknown), (unknown), Thomas J. Keefe, Michael P. Crawford	10
12	Non‐adrenergic non‐cholinergic (NANC) excitatory response of the channel catfish intestine 1994 ·Journal of Autonomic Pharmacology ·C. S. Venugopalan, (unknown), (unknown), Kevin M. Kleinow	3
13	Evidence for vasoactive intestinal peptide as a mediator of non‐adrenergic non‐cholinergic neurotransmission in the trachea 1990 ·Journal of Autonomic Pharmacology ·C. S. Venugopalan, (unknown), (unknown)	7
14	Epithelial influence on the tracheal non‐adrenergic inhibitory response 1990 ·Journal of Autonomic Pharmacology ·C. S. Venugopalan, (unknown), (unknown), (unknown)	1
15	Vasoactive intestinal peptide (VIP), a putative neurotransmitter of nonadrenergic, noncholinergic (NANC) inhibitory innervation and its relevance to therapy 1989 ·Journal of Veterinary Pharmacology and Therapeutics ·C. S. Venugopalan	6
16	The functional conversion hypothesis: A contributor to exercise-induced asthma? 1988 ·Medical Hypotheses ·C. S. Venugopalan, Howard J. Jenkins, Jeffrey M. Drazen	4
17	Cross‐desensitization of VIP‐ and NANC‐ mediated inhibition of the guinea‐pig tracheal pouch 1988 ·Journal of Autonomic Pharmacology ·C. S. Venugopalan, (unknown)	8
18	Contractile responses to histamine of isolated pulmonary artery strips from healthy and heartworm-infected dogs 1985 ·American Journal of Veterinary Research ·(unknown), C. S. Venugopalan, (unknown)	2
19	Assessment of smooth muscle function in Sesbania drummondii toxicosis in Gallus domesticus 1984 ·American Journal of Veterinary Research ·C. S. Venugopalan, Wayne Flory, (unknown), (unknown), George M. Strain	3
20	Inhibition of bronchoconstriction in the guinea pig by a calcium channel blocker, nifedipine. 1982 ·PubMed ·Christopher H. Fanta, C. S. Venugopalan, Peter G. Lacouture, Jeffrey M. Drazen	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact